Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Glutathione Peroxidase | 21 | 2022 | 256 | 3.510 |
Why?
|
Selenium | 9 | 2022 | 416 | 1.680 |
Why?
|
Selenoproteins | 8 | 2021 | 214 | 1.430 |
Why?
|
Endothelial Cells | 12 | 2021 | 3537 | 1.350 |
Why?
|
Homocysteine | 12 | 2016 | 640 | 1.300 |
Why?
|
Selenocysteine | 7 | 2022 | 127 | 1.250 |
Why?
|
S-Adenosylhomocysteine | 3 | 2021 | 41 | 1.170 |
Why?
|
Antioxidants | 14 | 2022 | 1668 | 0.890 |
Why?
|
Oxidation-Reduction | 17 | 2021 | 2222 | 0.810 |
Why?
|
Oxidants | 5 | 2013 | 169 | 0.790 |
Why?
|
Reactive Oxygen Species | 15 | 2022 | 2138 | 0.780 |
Why?
|
Cardiovascular Physiological Phenomena | 1 | 2021 | 239 | 0.690 |
Why?
|
Oxidative Stress | 18 | 2022 | 3107 | 0.690 |
Why?
|
Receptors, Adrenergic, alpha-2 | 9 | 2003 | 69 | 0.570 |
Why?
|
Hyperhomocysteinemia | 7 | 2016 | 118 | 0.560 |
Why?
|
Glucosephosphate Dehydrogenase | 7 | 2019 | 210 | 0.560 |
Why?
|
Myocardial Reperfusion Injury | 3 | 2016 | 479 | 0.540 |
Why?
|
Mitogen-Activated Protein Kinase Phosphatases | 2 | 2013 | 46 | 0.540 |
Why?
|
Dual-Specificity Phosphatases | 2 | 2013 | 70 | 0.530 |
Why?
|
NF-kappa B | 3 | 2015 | 2486 | 0.530 |
Why?
|
Blood Vessels | 3 | 2013 | 1112 | 0.520 |
Why?
|
RNA, Transfer, Amino Acyl | 2 | 2014 | 46 | 0.500 |
Why?
|
Methyltransferases | 2 | 2015 | 373 | 0.480 |
Why?
|
Systems Biology | 2 | 2019 | 479 | 0.470 |
Why?
|
NF-E2-Related Factor 2 | 1 | 2016 | 376 | 0.450 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2017 | 995 | 0.390 |
Why?
|
S-Adenosylmethionine | 3 | 2021 | 213 | 0.390 |
Why?
|
Mitochondrial Proteins | 1 | 2017 | 979 | 0.380 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2017 | 1137 | 0.370 |
Why?
|
Hydrogen Peroxide | 4 | 2014 | 732 | 0.370 |
Why?
|
Receptors, Adrenergic, alpha | 4 | 1996 | 146 | 0.370 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2013 | 4357 | 0.370 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2013 | 616 | 0.360 |
Why?
|
Nitric Oxide | 8 | 2016 | 2141 | 0.330 |
Why?
|
Arginine | 4 | 2018 | 934 | 0.330 |
Why?
|
Cardiovascular System | 1 | 2016 | 850 | 0.330 |
Why?
|
Drug Repositioning | 3 | 2022 | 231 | 0.320 |
Why?
|
Arteriosclerosis | 3 | 2004 | 1064 | 0.320 |
Why?
|
Glucosephosphate Dehydrogenase Deficiency | 5 | 2009 | 94 | 0.310 |
Why?
|
Mitochondria, Liver | 1 | 2009 | 190 | 0.310 |
Why?
|
Methylation | 5 | 2021 | 1080 | 0.310 |
Why?
|
Cardiomyopathies | 2 | 2016 | 1945 | 0.290 |
Why?
|
Sulfhydryl Compounds | 3 | 2012 | 299 | 0.270 |
Why?
|
Muscle, Smooth, Vascular | 6 | 2012 | 1484 | 0.270 |
Why?
|
Gene Expression Regulation | 10 | 2021 | 11902 | 0.260 |
Why?
|
Nitrates | 2 | 2009 | 264 | 0.260 |
Why?
|
MAP Kinase Signaling System | 2 | 2011 | 1483 | 0.250 |
Why?
|
Aminoglycosides | 1 | 2005 | 163 | 0.250 |
Why?
|
Cardiovascular Diseases | 5 | 2022 | 15740 | 0.240 |
Why?
|
Transcriptional Activation | 2 | 2010 | 1755 | 0.240 |
Why?
|
Thrombosis | 5 | 2018 | 3052 | 0.230 |
Why?
|
Protein Processing, Post-Translational | 2 | 2016 | 1977 | 0.230 |
Why?
|
Cell Adhesion Molecules | 1 | 2010 | 1602 | 0.220 |
Why?
|
DNA-Binding Proteins | 4 | 2017 | 9590 | 0.220 |
Why?
|
Animals | 55 | 2022 | 167940 | 0.210 |
Why?
|
Glycine | 2 | 2009 | 663 | 0.210 |
Why?
|
Apolipoproteins E | 2 | 2006 | 1437 | 0.200 |
Why?
|
Lipopolysaccharides | 1 | 2010 | 2214 | 0.200 |
Why?
|
Glucose | 3 | 2021 | 4361 | 0.200 |
Why?
|
Nitric Oxide Synthase | 1 | 2004 | 908 | 0.190 |
Why?
|
Core Binding Factor Alpha 1 Subunit | 2 | 2012 | 158 | 0.190 |
Why?
|
Nitric Oxide Synthase Type III | 2 | 2016 | 704 | 0.190 |
Why?
|
Myocytes, Smooth Muscle | 4 | 2012 | 685 | 0.190 |
Why?
|
Transcription Factors | 5 | 2019 | 12100 | 0.190 |
Why?
|
CCAAT-Enhancer-Binding Proteins | 2 | 1995 | 286 | 0.190 |
Why?
|
Cells, Cultured | 13 | 2021 | 18968 | 0.190 |
Why?
|
Promoter Regions, Genetic | 9 | 2011 | 5784 | 0.190 |
Why?
|
Pre-Eclampsia | 2 | 2023 | 1230 | 0.190 |
Why?
|
Protein Biosynthesis | 2 | 2005 | 2104 | 0.180 |
Why?
|
Coronary Vessels | 4 | 2021 | 3112 | 0.180 |
Why?
|
Aldosterone | 3 | 2012 | 868 | 0.180 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 3 | 2021 | 620 | 0.180 |
Why?
|
Myoblasts, Skeletal | 1 | 2020 | 76 | 0.180 |
Why?
|
Bone Morphogenetic Protein 2 | 2 | 2012 | 342 | 0.180 |
Why?
|
Free Radical Scavengers | 1 | 2021 | 211 | 0.170 |
Why?
|
NADP | 3 | 2017 | 223 | 0.170 |
Why?
|
Signal Transduction | 8 | 2021 | 23363 | 0.170 |
Why?
|
Tryptophan | 1 | 2021 | 480 | 0.170 |
Why?
|
Allopurinol | 1 | 2021 | 200 | 0.170 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 3 | 2011 | 694 | 0.170 |
Why?
|
Dietary Supplements | 5 | 2016 | 3389 | 0.170 |
Why?
|
Paracrine Communication | 1 | 2020 | 278 | 0.160 |
Why?
|
Iodide Peroxidase | 1 | 2020 | 294 | 0.160 |
Why?
|
Muscle Development | 1 | 2020 | 261 | 0.160 |
Why?
|
Gene Expression Regulation, Enzymologic | 4 | 2017 | 1173 | 0.160 |
Why?
|
Mitochondria | 1 | 2012 | 3598 | 0.160 |
Why?
|
Energy Metabolism | 2 | 2021 | 2869 | 0.160 |
Why?
|
RNA, Messenger | 11 | 2023 | 12762 | 0.150 |
Why?
|
Hyperuricemia | 1 | 2021 | 224 | 0.150 |
Why?
|
Enzyme Activation | 5 | 2011 | 3604 | 0.150 |
Why?
|
Endothelium, Vascular | 7 | 2011 | 4437 | 0.150 |
Why?
|
Neovascularization, Physiologic | 2 | 2020 | 1335 | 0.150 |
Why?
|
Epigenesis, Genetic | 1 | 2011 | 3758 | 0.150 |
Why?
|
COS Cells | 4 | 2009 | 1129 | 0.140 |
Why?
|
alpha-Crystallin B Chain | 1 | 2016 | 24 | 0.140 |
Why?
|
Heart Failure | 3 | 2021 | 11835 | 0.140 |
Why?
|
Cyclic GMP | 2 | 2016 | 395 | 0.140 |
Why?
|
Intercellular Adhesion Molecule-1 | 2 | 2011 | 1128 | 0.140 |
Why?
|
Platelet Aggregation | 2 | 2018 | 805 | 0.140 |
Why?
|
Disulfides | 2 | 2009 | 466 | 0.140 |
Why?
|
TATA Box | 2 | 1995 | 127 | 0.140 |
Why?
|
Mammals | 1 | 2022 | 1129 | 0.140 |
Why?
|
Proto-Oncogene Proteins c-jun | 1 | 2017 | 285 | 0.140 |
Why?
|
Cell Line | 7 | 2020 | 15626 | 0.130 |
Why?
|
Cell Hypoxia | 2 | 2017 | 657 | 0.130 |
Why?
|
Cell Survival | 3 | 2016 | 5796 | 0.130 |
Why?
|
Cell Proliferation | 6 | 2021 | 10434 | 0.130 |
Why?
|
Base Sequence | 12 | 2004 | 12447 | 0.130 |
Why?
|
Proteome | 1 | 2006 | 1856 | 0.130 |
Why?
|
Inflammation | 1 | 2015 | 10757 | 0.130 |
Why?
|
Gene Knockdown Techniques | 2 | 2011 | 1617 | 0.130 |
Why?
|
Vitamin B 12 Deficiency | 1 | 2016 | 119 | 0.130 |
Why?
|
Humans | 55 | 2023 | 760261 | 0.120 |
Why?
|
Polymorphism, Genetic | 4 | 2011 | 4286 | 0.120 |
Why?
|
Phosphoric Diester Hydrolases | 1 | 2016 | 199 | 0.120 |
Why?
|
Phosphodiesterase Inhibitors | 1 | 2016 | 214 | 0.120 |
Why?
|
Genes, MHC Class I | 3 | 1993 | 240 | 0.120 |
Why?
|
Podocytes | 1 | 2019 | 402 | 0.120 |
Why?
|
RNA, Transfer, Ser | 1 | 2014 | 7 | 0.120 |
Why?
|
Genes, Regulator | 1 | 1995 | 374 | 0.120 |
Why?
|
Ubiquitination | 1 | 2019 | 1010 | 0.120 |
Why?
|
Molecular Sequence Data | 10 | 2011 | 17628 | 0.110 |
Why?
|
Cattle | 4 | 2012 | 3847 | 0.110 |
Why?
|
Pregnancy Trimester, Third | 1 | 2016 | 582 | 0.110 |
Why?
|
Fatty Acids | 1 | 2021 | 1805 | 0.110 |
Why?
|
NAD | 1 | 2017 | 610 | 0.110 |
Why?
|
Myocardial Contraction | 4 | 2011 | 1516 | 0.110 |
Why?
|
MicroRNAs | 2 | 2023 | 3784 | 0.110 |
Why?
|
Plasma | 1 | 2016 | 584 | 0.110 |
Why?
|
Interferon-gamma | 1 | 2021 | 3160 | 0.110 |
Why?
|
Gene Expression | 6 | 2011 | 7592 | 0.100 |
Why?
|
Receptor, Endothelin B | 1 | 2012 | 46 | 0.100 |
Why?
|
Mice, Knockout | 12 | 2020 | 14396 | 0.100 |
Why?
|
Pregnancy Trimester, First | 1 | 2016 | 909 | 0.100 |
Why?
|
Leukocytes | 2 | 2014 | 2030 | 0.100 |
Why?
|
Hypertension, Pulmonary | 2 | 2013 | 1570 | 0.100 |
Why?
|
Aorta, Thoracic | 1 | 1998 | 1097 | 0.100 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 2 | 2011 | 478 | 0.100 |
Why?
|
Rats | 14 | 2019 | 23695 | 0.100 |
Why?
|
Diabetic Nephropathies | 1 | 2019 | 988 | 0.100 |
Why?
|
Chemokine CXCL12 | 1 | 2013 | 454 | 0.100 |
Why?
|
Models, Biological | 5 | 2016 | 9468 | 0.100 |
Why?
|
Regeneration | 1 | 2020 | 1506 | 0.100 |
Why?
|
Apoptosis | 6 | 2019 | 9497 | 0.090 |
Why?
|
Phosphatidylethanolamines | 1 | 2011 | 129 | 0.090 |
Why?
|
Blood Proteins | 1 | 2016 | 1172 | 0.090 |
Why?
|
Cysteine | 3 | 2012 | 897 | 0.090 |
Why?
|
11-beta-Hydroxysteroid Dehydrogenase Type 1 | 1 | 2010 | 20 | 0.090 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2020 | 3483 | 0.090 |
Why?
|
Mice | 27 | 2020 | 81216 | 0.090 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 2 | 2011 | 688 | 0.090 |
Why?
|
Computer Simulation | 3 | 2019 | 6210 | 0.090 |
Why?
|
Glutathione | 5 | 2012 | 582 | 0.090 |
Why?
|
I-kappa B Kinase | 1 | 2011 | 251 | 0.090 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2011 | 474 | 0.090 |
Why?
|
Cholelithiasis | 1 | 2011 | 408 | 0.080 |
Why?
|
RNA-Binding Proteins | 2 | 2017 | 1892 | 0.080 |
Why?
|
Kidney Tubules, Proximal | 1 | 2011 | 382 | 0.080 |
Why?
|
Dose-Response Relationship, Drug | 5 | 2016 | 10829 | 0.080 |
Why?
|
Uncoupling Agents | 1 | 2009 | 46 | 0.080 |
Why?
|
Sodium Selenite | 1 | 2008 | 11 | 0.080 |
Why?
|
Transfection | 6 | 2009 | 5782 | 0.080 |
Why?
|
Selenomethionine | 1 | 2008 | 18 | 0.080 |
Why?
|
Cell Adhesion | 2 | 2014 | 3096 | 0.080 |
Why?
|
Myocytes, Cardiac | 2 | 2011 | 1656 | 0.080 |
Why?
|
Cell Death | 2 | 2012 | 1670 | 0.080 |
Why?
|
Organoselenium Compounds | 1 | 2008 | 21 | 0.080 |
Why?
|
Homeostasis | 2 | 2017 | 3305 | 0.080 |
Why?
|
Microvessels | 1 | 2013 | 572 | 0.080 |
Why?
|
Transcription, Genetic | 5 | 1996 | 7593 | 0.080 |
Why?
|
Receptors, Glucocorticoid | 1 | 2010 | 296 | 0.080 |
Why?
|
Catalase | 1 | 2009 | 216 | 0.080 |
Why?
|
H-2 Antigens | 2 | 1993 | 358 | 0.080 |
Why?
|
Myocardium | 2 | 2012 | 4688 | 0.080 |
Why?
|
Vasodilation | 2 | 2009 | 964 | 0.080 |
Why?
|
Guanylate Cyclase | 1 | 2009 | 205 | 0.080 |
Why?
|
Superoxides | 2 | 2006 | 387 | 0.070 |
Why?
|
Brachial Artery | 1 | 2009 | 368 | 0.070 |
Why?
|
Vitamin D | 2 | 2023 | 3293 | 0.070 |
Why?
|
DNA Methylation | 2 | 2012 | 4374 | 0.070 |
Why?
|
Infarction, Middle Cerebral Artery | 1 | 2011 | 485 | 0.070 |
Why?
|
3' Untranslated Regions | 2 | 2009 | 514 | 0.070 |
Why?
|
Creatine | 1 | 2009 | 426 | 0.070 |
Why?
|
Amylases | 1 | 1987 | 169 | 0.070 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2018 | 2129 | 0.070 |
Why?
|
Polysaccharides | 1 | 2013 | 1016 | 0.070 |
Why?
|
Luciferases | 2 | 2005 | 716 | 0.070 |
Why?
|
Biological Availability | 1 | 2007 | 395 | 0.070 |
Why?
|
Atherosclerosis | 3 | 2008 | 3524 | 0.070 |
Why?
|
Intracranial Thrombosis | 1 | 2007 | 109 | 0.070 |
Why?
|
DNA, Complementary | 3 | 2005 | 1993 | 0.070 |
Why?
|
Nitric Oxide Synthase Type II | 2 | 2006 | 514 | 0.070 |
Why?
|
Histocompatibility Antigens Class I | 2 | 1993 | 1354 | 0.070 |
Why?
|
Disease Models, Animal | 6 | 2018 | 18134 | 0.070 |
Why?
|
Methionine | 2 | 2009 | 569 | 0.070 |
Why?
|
Nitrosation | 1 | 2006 | 25 | 0.070 |
Why?
|
Extracellular Fluid | 1 | 2008 | 165 | 0.070 |
Why?
|
Amebicides | 1 | 2005 | 7 | 0.070 |
Why?
|
Vasoconstriction | 2 | 2000 | 592 | 0.070 |
Why?
|
Epidermal Growth Factor | 1 | 2009 | 695 | 0.070 |
Why?
|
Cystathionine beta-Synthase | 1 | 2005 | 27 | 0.070 |
Why?
|
Transduction, Genetic | 1 | 2009 | 897 | 0.070 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2013 | 1655 | 0.070 |
Why?
|
DNA Mutational Analysis | 3 | 2006 | 4109 | 0.060 |
Why?
|
Albuminuria | 1 | 2009 | 659 | 0.060 |
Why?
|
Codon, Terminator | 1 | 2005 | 125 | 0.060 |
Why?
|
Endoplasmic Reticulum | 1 | 2011 | 1135 | 0.060 |
Why?
|
Muscle, Skeletal | 1 | 2020 | 4923 | 0.060 |
Why?
|
Down-Regulation | 3 | 2012 | 2918 | 0.060 |
Why?
|
Heart Diseases | 1 | 2018 | 2809 | 0.060 |
Why?
|
Ornithine | 1 | 2004 | 79 | 0.060 |
Why?
|
Adenoviridae | 1 | 2009 | 1084 | 0.060 |
Why?
|
Genes, Reporter | 2 | 2005 | 1531 | 0.060 |
Why?
|
Mice, Inbred C57BL | 8 | 2020 | 22025 | 0.060 |
Why?
|
Carrier Proteins | 1 | 2017 | 4938 | 0.060 |
Why?
|
Coronary Artery Disease | 4 | 2018 | 6661 | 0.060 |
Why?
|
Metabolic Networks and Pathways | 2 | 2019 | 788 | 0.060 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2018 | 2296 | 0.060 |
Why?
|
Codon | 1 | 2005 | 602 | 0.060 |
Why?
|
Cloning, Molecular | 4 | 2005 | 4172 | 0.060 |
Why?
|
Recombinant Proteins | 3 | 2009 | 6543 | 0.060 |
Why?
|
Aorta | 3 | 2006 | 2042 | 0.060 |
Why?
|
Protein Conformation | 1 | 2011 | 3969 | 0.050 |
Why?
|
Dexamethasone | 1 | 2010 | 1928 | 0.050 |
Why?
|
Amino Acid Sequence | 4 | 2011 | 13456 | 0.050 |
Why?
|
RNA Splicing | 1 | 1988 | 914 | 0.050 |
Why?
|
Tumor Cells, Cultured | 3 | 1996 | 6131 | 0.050 |
Why?
|
NFI Transcription Factors | 2 | 1995 | 42 | 0.050 |
Why?
|
Y-Box-Binding Protein 1 | 2 | 1995 | 41 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2009 | 2449 | 0.050 |
Why?
|
Databases, Factual | 1 | 2018 | 8018 | 0.050 |
Why?
|
Calcinosis | 1 | 2011 | 1478 | 0.050 |
Why?
|
Adenosine Triphosphate | 1 | 2009 | 1995 | 0.050 |
Why?
|
Algorithms | 2 | 2022 | 13967 | 0.050 |
Why?
|
Blotting, Western | 2 | 2010 | 5039 | 0.050 |
Why?
|
Insulin-Secreting Cells | 1 | 2009 | 907 | 0.050 |
Why?
|
Angiotensin II | 1 | 2005 | 850 | 0.050 |
Why?
|
Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2003 | 275 | 0.050 |
Why?
|
Cholesterol | 1 | 2011 | 2925 | 0.050 |
Why?
|
Neoplasms | 1 | 2011 | 22066 | 0.050 |
Why?
|
Nanoparticles | 1 | 2013 | 1938 | 0.050 |
Why?
|
Rats, Sprague-Dawley | 4 | 2019 | 8157 | 0.050 |
Why?
|
Computational Biology | 1 | 2013 | 3504 | 0.050 |
Why?
|
Extracellular Space | 2 | 2017 | 565 | 0.050 |
Why?
|
Liver | 3 | 2011 | 7512 | 0.050 |
Why?
|
Kynurenine | 1 | 2021 | 140 | 0.050 |
Why?
|
Hyperglycemia | 1 | 2009 | 1380 | 0.050 |
Why?
|
Xanthine Oxidase | 1 | 2021 | 69 | 0.050 |
Why?
|
Rats, Wistar | 3 | 2011 | 1849 | 0.050 |
Why?
|
Histones | 1 | 2011 | 2583 | 0.050 |
Why?
|
Hematinics | 1 | 2003 | 281 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 5 | 2011 | 17766 | 0.040 |
Why?
|
Enzyme Inhibitors | 1 | 2011 | 3726 | 0.040 |
Why?
|
Repetitive Sequences, Nucleic Acid | 2 | 1996 | 783 | 0.040 |
Why?
|
Blood Platelets | 1 | 2011 | 2522 | 0.040 |
Why?
|
Cytosol | 1 | 2003 | 887 | 0.040 |
Why?
|
Up-Regulation | 3 | 2020 | 4127 | 0.040 |
Why?
|
Adenosine | 1 | 2005 | 833 | 0.040 |
Why?
|
Risk Factors | 7 | 2018 | 74269 | 0.040 |
Why?
|
Holistic Health | 1 | 2019 | 46 | 0.040 |
Why?
|
Ouabain | 1 | 2019 | 247 | 0.040 |
Why?
|
Adrenergic alpha-Agonists | 1 | 2000 | 178 | 0.040 |
Why?
|
Blood-Brain Barrier | 1 | 2005 | 1017 | 0.040 |
Why?
|
Mice, Mutant Strains | 3 | 2009 | 1760 | 0.040 |
Why?
|
Hypertension | 5 | 2005 | 8595 | 0.040 |
Why?
|
Cell Movement | 2 | 2021 | 5206 | 0.040 |
Why?
|
Blood Glucose | 2 | 2011 | 6375 | 0.040 |
Why?
|
Mass Spectrometry | 1 | 2005 | 2192 | 0.040 |
Why?
|
Venous Thrombosis | 1 | 2007 | 1293 | 0.040 |
Why?
|
Male | 25 | 2021 | 359413 | 0.040 |
Why?
|
Chromosomes, Human, Pair 18 | 1 | 1998 | 246 | 0.040 |
Why?
|
Mice, Inbred DBA | 1 | 2019 | 622 | 0.040 |
Why?
|
Protein Binding | 2 | 2021 | 9336 | 0.040 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 2 | 2012 | 482 | 0.040 |
Why?
|
Carbamazepine | 1 | 2018 | 224 | 0.040 |
Why?
|
Glycolysis | 1 | 2021 | 828 | 0.040 |
Why?
|
Desoxycorticosterone | 1 | 1996 | 46 | 0.040 |
Why?
|
Norepinephrine | 1 | 2000 | 900 | 0.040 |
Why?
|
In Situ Hybridization | 2 | 1998 | 1900 | 0.040 |
Why?
|
Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2019 | 307 | 0.040 |
Why?
|
Genetic Linkage | 2 | 1999 | 2381 | 0.040 |
Why?
|
Kidney | 4 | 2019 | 7072 | 0.030 |
Why?
|
Hypertension, Renal | 1 | 1996 | 141 | 0.030 |
Why?
|
Folic Acid | 1 | 2003 | 1309 | 0.030 |
Why?
|
Intracellular Space | 1 | 2017 | 197 | 0.030 |
Why?
|
Sodium Chloride, Dietary | 1 | 1999 | 293 | 0.030 |
Why?
|
DNA Footprinting | 1 | 1996 | 97 | 0.030 |
Why?
|
Vasoconstrictor Agents | 1 | 2000 | 651 | 0.030 |
Why?
|
Spironolactone | 2 | 2012 | 411 | 0.030 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2011 | 12281 | 0.030 |
Why?
|
Genetic Vectors | 1 | 2005 | 3378 | 0.030 |
Why?
|
P-Selectin | 2 | 2011 | 600 | 0.030 |
Why?
|
Oligonucleotide Probes | 1 | 1996 | 418 | 0.030 |
Why?
|
Sp1 Transcription Factor | 1 | 1996 | 140 | 0.030 |
Why?
|
Hypotension, Orthostatic | 1 | 1998 | 256 | 0.030 |
Why?
|
Poly A | 2 | 1992 | 181 | 0.030 |
Why?
|
Evidence-Based Medicine | 1 | 2007 | 3696 | 0.030 |
Why?
|
Consensus Sequence | 1 | 1995 | 367 | 0.030 |
Why?
|
Oncogene Protein p21(ras) | 1 | 1995 | 68 | 0.030 |
Why?
|
Insulinoma | 1 | 1995 | 121 | 0.030 |
Why?
|
Restriction Mapping | 2 | 1992 | 852 | 0.030 |
Why?
|
Phenotype | 2 | 2011 | 16543 | 0.030 |
Why?
|
Uric Acid | 1 | 2021 | 807 | 0.030 |
Why?
|
Drug Therapy, Computer-Assisted | 1 | 2016 | 198 | 0.030 |
Why?
|
RNA | 3 | 1993 | 2721 | 0.030 |
Why?
|
Blood Pressure | 6 | 2000 | 8523 | 0.030 |
Why?
|
Mutation | 6 | 2009 | 29950 | 0.030 |
Why?
|
Hydroxychloroquine | 1 | 2018 | 428 | 0.030 |
Why?
|
Oligodeoxyribonucleotides | 2 | 1993 | 778 | 0.030 |
Why?
|
Monocrotaline | 1 | 2013 | 27 | 0.030 |
Why?
|
Drug Discovery | 1 | 2022 | 1056 | 0.030 |
Why?
|
DNA | 4 | 1999 | 7236 | 0.030 |
Why?
|
Glutamic Acid | 1 | 1999 | 1166 | 0.030 |
Why?
|
Polypharmacy | 1 | 2016 | 307 | 0.030 |
Why?
|
Isoprostanes | 1 | 2012 | 19 | 0.030 |
Why?
|
Myocardial Ischemia | 1 | 2004 | 2161 | 0.030 |
Why?
|
Chloramphenicol O-Acetyltransferase | 1 | 1992 | 221 | 0.030 |
Why?
|
Brain Ischemia | 1 | 2006 | 3127 | 0.030 |
Why?
|
Protein Transport | 2 | 2012 | 1966 | 0.030 |
Why?
|
Protein Kinase C | 2 | 2009 | 1201 | 0.030 |
Why?
|
Stem Cells | 1 | 2005 | 3525 | 0.030 |
Why?
|
Time Factors | 4 | 2013 | 40133 | 0.030 |
Why?
|
Dextran Sulfate | 1 | 2013 | 255 | 0.030 |
Why?
|
Ribonucleases | 1 | 1993 | 277 | 0.030 |
Why?
|
Diabetes Mellitus | 1 | 2011 | 5884 | 0.030 |
Why?
|
Leukemia, Erythroblastic, Acute | 1 | 1992 | 176 | 0.030 |
Why?
|
Tissue Distribution | 2 | 1993 | 2262 | 0.030 |
Why?
|
Chitosan | 1 | 2013 | 132 | 0.030 |
Why?
|
Electron Probe Microanalysis | 1 | 2011 | 32 | 0.030 |
Why?
|
Colonic Neoplasms | 2 | 1995 | 2526 | 0.030 |
Why?
|
Conserved Sequence | 1 | 1995 | 1168 | 0.030 |
Why?
|
Binding Sites | 2 | 2004 | 6050 | 0.030 |
Why?
|
Selenoprotein P | 1 | 2011 | 33 | 0.020 |
Why?
|
Jurkat Cells | 1 | 2013 | 736 | 0.020 |
Why?
|
Rabbits | 1 | 1998 | 4773 | 0.020 |
Why?
|
Mole Rats | 1 | 2011 | 27 | 0.020 |
Why?
|
Receptors, Adrenergic | 1 | 1991 | 155 | 0.020 |
Why?
|
Nucleic Acid Hybridization | 1 | 1993 | 1304 | 0.020 |
Why?
|
RNA, Transfer, Amino Acid-Specific | 1 | 2011 | 23 | 0.020 |
Why?
|
Molecular Probes | 1 | 1993 | 313 | 0.020 |
Why?
|
Bleeding Time | 1 | 2011 | 84 | 0.020 |
Why?
|
Pulmonary Wedge Pressure | 1 | 2012 | 273 | 0.020 |
Why?
|
Spectrometry, X-Ray Emission | 1 | 2011 | 143 | 0.020 |
Why?
|
Aerosols | 1 | 2013 | 633 | 0.020 |
Why?
|
Receptors, Dopamine | 1 | 1991 | 292 | 0.020 |
Why?
|
Heterozygote | 2 | 2009 | 2797 | 0.020 |
Why?
|
Haplotypes | 2 | 2007 | 2764 | 0.020 |
Why?
|
Basement Membrane | 1 | 2011 | 348 | 0.020 |
Why?
|
Endothelin-1 | 1 | 2012 | 302 | 0.020 |
Why?
|
Propensity Score | 1 | 2018 | 1918 | 0.020 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2016 | 1346 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2019 | 1740 | 0.020 |
Why?
|
Thioredoxins | 1 | 2011 | 201 | 0.020 |
Why?
|
Sequence Homology, Nucleic Acid | 2 | 1991 | 1056 | 0.020 |
Why?
|
Adenosine Diphosphate | 1 | 2011 | 429 | 0.020 |
Why?
|
Kidney Cortex | 1 | 2009 | 169 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2019 | 4264 | 0.020 |
Why?
|
Genotype | 4 | 2011 | 12959 | 0.020 |
Why?
|
Oligonucleotides | 1 | 2012 | 588 | 0.020 |
Why?
|
Arrhythmias, Cardiac | 1 | 2019 | 2255 | 0.020 |
Why?
|
Nitrites | 1 | 2009 | 159 | 0.020 |
Why?
|
DNA Primers | 2 | 2007 | 2819 | 0.020 |
Why?
|
Terminology as Topic | 1 | 2016 | 1534 | 0.020 |
Why?
|
I-kappa B Proteins | 1 | 2009 | 212 | 0.020 |
Why?
|
Base Composition | 1 | 1989 | 290 | 0.020 |
Why?
|
Pregnancy | 2 | 2023 | 29725 | 0.020 |
Why?
|
Gene Knockout Techniques | 1 | 2011 | 803 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2019 | 5201 | 0.020 |
Why?
|
Coronary Disease | 1 | 2003 | 5993 | 0.020 |
Why?
|
Peroxynitrous Acid | 1 | 2008 | 42 | 0.020 |
Why?
|
Nucleic Acid Precursors | 1 | 1988 | 15 | 0.020 |
Why?
|
Brain | 4 | 2005 | 26912 | 0.020 |
Why?
|
bcl-2-Associated X Protein | 1 | 2009 | 282 | 0.020 |
Why?
|
Aerobiosis | 1 | 2008 | 101 | 0.020 |
Why?
|
Hyperemia | 1 | 2009 | 221 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2019 | 2805 | 0.020 |
Why?
|
Protein Kinases | 1 | 1995 | 1612 | 0.020 |
Why?
|
Nuclear Proteins | 2 | 1995 | 5793 | 0.020 |
Why?
|
Polymorphism, Single-Stranded Conformational | 1 | 2007 | 330 | 0.020 |
Why?
|
Diet | 3 | 2012 | 8008 | 0.020 |
Why?
|
Stroke | 2 | 2007 | 9945 | 0.020 |
Why?
|
Female | 11 | 2023 | 391011 | 0.020 |
Why?
|
Creatine Kinase | 1 | 2009 | 691 | 0.020 |
Why?
|
Stroke Volume | 1 | 2021 | 5513 | 0.020 |
Why?
|
Genetic Markers | 2 | 2006 | 2608 | 0.020 |
Why?
|
Epigenomics | 1 | 2012 | 936 | 0.020 |
Why?
|
Cyclic AMP Response Element Modulator | 1 | 2007 | 88 | 0.020 |
Why?
|
Gene Frequency | 2 | 2006 | 3605 | 0.020 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2007 | 295 | 0.020 |
Why?
|
Yohimbine | 2 | 2000 | 62 | 0.020 |
Why?
|
Genes | 2 | 1987 | 1845 | 0.020 |
Why?
|
Ascorbic Acid | 1 | 2009 | 655 | 0.020 |
Why?
|
Diet, Atherogenic | 1 | 2006 | 93 | 0.020 |
Why?
|
Cell Membrane | 2 | 2003 | 3683 | 0.020 |
Why?
|
Evans Blue | 1 | 2005 | 42 | 0.020 |
Why?
|
Regional Blood Flow | 1 | 2009 | 1490 | 0.020 |
Why?
|
Salivary Glands | 1 | 1987 | 229 | 0.020 |
Why?
|
Insulin | 2 | 2011 | 6592 | 0.020 |
Why?
|
Hyperaldosteronism | 1 | 2009 | 244 | 0.020 |
Why?
|
Fibrosis | 1 | 2012 | 2042 | 0.020 |
Why?
|
Blotting, Northern | 1 | 2007 | 1544 | 0.020 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 1989 | 789 | 0.020 |
Why?
|
Introns | 1 | 1988 | 978 | 0.020 |
Why?
|
Receptors, Purinergic P1 | 1 | 2005 | 108 | 0.020 |
Why?
|
Homozygote | 1 | 2009 | 1786 | 0.020 |
Why?
|
Enzyme Induction | 1 | 2005 | 452 | 0.010 |
Why?
|
Metalloporphyrins | 1 | 2004 | 41 | 0.010 |
Why?
|
Ribose | 1 | 2004 | 63 | 0.010 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2007 | 859 | 0.010 |
Why?
|
Clinical Trials as Topic | 2 | 2011 | 8058 | 0.010 |
Why?
|
Hormones | 1 | 2007 | 867 | 0.010 |
Why?
|
Blood Physiological Phenomena | 1 | 2003 | 53 | 0.010 |
Why?
|
Cell Nucleus | 1 | 1992 | 2909 | 0.010 |
Why?
|
Transcription Initiation Site | 1 | 2004 | 186 | 0.010 |
Why?
|
Hindlimb | 1 | 2005 | 510 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2018 | 12532 | 0.010 |
Why?
|
Immunoblotting | 1 | 2007 | 1649 | 0.010 |
Why?
|
Pulmonary Artery | 1 | 2012 | 1919 | 0.010 |
Why?
|
Hypertrophy | 1 | 2005 | 555 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2012 | 3443 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 4573 | 0.010 |
Why?
|
Phosphotransferases | 1 | 2004 | 303 | 0.010 |
Why?
|
Cyclic AMP | 1 | 2007 | 1455 | 0.010 |
Why?
|
Arterioles | 1 | 2003 | 250 | 0.010 |
Why?
|
Organ Size | 2 | 1999 | 2249 | 0.010 |
Why?
|
Subcellular Fractions | 1 | 2003 | 532 | 0.010 |
Why?
|
Enhancer Elements, Genetic | 1 | 1989 | 1356 | 0.010 |
Why?
|
Gene Transfer Techniques | 1 | 2007 | 1204 | 0.010 |
Why?
|
RNA, Transfer | 1 | 2004 | 289 | 0.010 |
Why?
|
Tyrosine | 1 | 2006 | 1440 | 0.010 |
Why?
|
HLA Antigens | 1 | 1987 | 1369 | 0.010 |
Why?
|
Blood Coagulation | 1 | 2006 | 1156 | 0.010 |
Why?
|
Adrenergic alpha-2 Receptor Antagonists | 1 | 2000 | 18 | 0.010 |
Why?
|
Prazosin | 1 | 2000 | 95 | 0.010 |
Why?
|
Middle Aged | 5 | 2021 | 220175 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2018 | 20048 | 0.010 |
Why?
|
Xenopus laevis | 1 | 2004 | 964 | 0.010 |
Why?
|
Phosphorylation | 2 | 2005 | 8314 | 0.010 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 1987 | 1765 | 0.010 |
Why?
|
Adrenergic alpha-Antagonists | 1 | 2000 | 174 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2021 | 64947 | 0.010 |
Why?
|
Adenine | 1 | 2005 | 976 | 0.010 |
Why?
|
Erythrocytes | 1 | 2008 | 2415 | 0.010 |
Why?
|
Recovery of Function | 1 | 2009 | 2982 | 0.010 |
Why?
|
Protein Isoforms | 1 | 2003 | 1697 | 0.010 |
Why?
|
Catecholamines | 1 | 1999 | 385 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2003 | 1246 | 0.010 |
Why?
|
Body Weight | 2 | 1999 | 4613 | 0.010 |
Why?
|
Incidence | 1 | 2016 | 21378 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2007 | 6242 | 0.010 |
Why?
|
Lod Score | 1 | 1998 | 602 | 0.010 |
Why?
|
Adolescent | 3 | 2016 | 87747 | 0.010 |
Why?
|
Pancreatic Neoplasms | 1 | 1995 | 5333 | 0.010 |
Why?
|
Prognosis | 1 | 2018 | 29636 | 0.010 |
Why?
|
Heart Rate | 2 | 1999 | 4169 | 0.010 |
Why?
|
Aged | 3 | 2021 | 168995 | 0.010 |
Why?
|
Sodium Chloride | 1 | 1999 | 596 | 0.010 |
Why?
|
Insulin Resistance | 1 | 2011 | 3960 | 0.010 |
Why?
|
Ischemia | 1 | 2005 | 1893 | 0.010 |
Why?
|
Constriction | 1 | 1996 | 171 | 0.010 |
Why?
|
Risk Assessment | 1 | 2018 | 24086 | 0.010 |
Why?
|
Ventricular Function, Left | 1 | 2009 | 3870 | 0.010 |
Why?
|
Sympathetic Nervous System | 1 | 1999 | 519 | 0.010 |
Why?
|
Ultrasonography | 1 | 2009 | 5960 | 0.010 |
Why?
|
Aging | 2 | 2009 | 8641 | 0.010 |
Why?
|
Genes, Dominant | 1 | 1998 | 863 | 0.010 |
Why?
|
Sex Factors | 1 | 2009 | 10530 | 0.010 |
Why?
|
Adenocarcinoma | 1 | 1992 | 6310 | 0.010 |
Why?
|
Adult | 4 | 2016 | 219847 | 0.010 |
Why?
|
Blood Pressure Determination | 1 | 1999 | 641 | 0.010 |
Why?
|
Lung Neoplasms | 1 | 2019 | 13249 | 0.010 |
Why?
|
Posture | 1 | 1998 | 954 | 0.010 |
Why?
|
Receptors, Cyclic AMP | 1 | 1993 | 20 | 0.010 |
Why?
|
Genetic Testing | 1 | 2006 | 3530 | 0.010 |
Why?
|
Creatinine | 1 | 1999 | 1906 | 0.010 |
Why?
|
Cricetulus | 1 | 1995 | 815 | 0.010 |
Why?
|
Nephrectomy | 1 | 1999 | 1017 | 0.010 |
Why?
|
Logistic Models | 1 | 2007 | 13311 | 0.010 |
Why?
|
Mice, Transgenic | 2 | 1996 | 9531 | 0.010 |
Why?
|
CHO Cells | 1 | 1995 | 1389 | 0.010 |
Why?
|
Rats, Inbred WKY | 1 | 1991 | 151 | 0.010 |
Why?
|
Rats, Inbred SHR | 1 | 1991 | 186 | 0.010 |
Why?
|
Cricetinae | 1 | 1995 | 2427 | 0.010 |
Why?
|
RNA Probes | 1 | 1991 | 111 | 0.010 |
Why?
|
Monitoring, Physiologic | 1 | 1999 | 1784 | 0.010 |
Why?
|
Genomic Library | 1 | 1991 | 189 | 0.010 |
Why?
|
Pedigree | 1 | 1998 | 4577 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 1998 | 4625 | 0.010 |
Why?
|
Calcium | 1 | 2003 | 5726 | 0.010 |
Why?
|
Binding, Competitive | 1 | 1991 | 1143 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 1999 | 6067 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 1999 | 2696 | 0.000 |
Why?
|
Cell Differentiation | 1 | 2005 | 11480 | 0.000 |
Why?
|
Alleles | 1 | 1999 | 6900 | 0.000 |
Why?
|
Gene Conversion | 1 | 1987 | 67 | 0.000 |
Why?
|
Prospective Studies | 1 | 2008 | 54263 | 0.000 |
Why?
|
Kinetics | 1 | 1991 | 6378 | 0.000 |
Why?
|
Research Design | 1 | 1996 | 6181 | 0.000 |
Why?
|
Child | 1 | 2006 | 79758 | 0.000 |
Why?
|